Mueller Brian 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Mueller Brian
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-15+11,400→ 92,648 total - Tax Payment
Common Stock
2024-03-15$83.87/sh−20,789$1,743,573→ 71,859 total - Award
Stock Option (Right to Buy Common Stock)
2024-03-15+25,540→ 25,540 totalExercise: $83.87From: 2025-03-15Exp: 2034-03-14→ Common Stock (25,540 underlying)
Footnotes (2)
- [F1]Restricted stock units granted March 15, 2024. Price not applicable.
- [F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.